207 related articles for article (PubMed ID: 16224211)
1. Lymphangiogenesis does not occur in breast cancer.
Agarwal B; Saxena R; Morimiya A; Mehrotra S; Badve S
Am J Surg Pathol; 2005 Nov; 29(11):1449-55. PubMed ID: 16224211
[TBL] [Abstract][Full Text] [Related]
2. Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study.
Van der Auwera I; Van den Eynden GG; Colpaert CG; Van Laere SJ; van Dam P; Van Marck EA; Dirix LY; Vermeulen PB
Clin Cancer Res; 2005 Nov; 11(21):7637-42. PubMed ID: 16278382
[TBL] [Abstract][Full Text] [Related]
3. Lymphatic vessel assessment by podoplanin (D2-40) immunohistochemistry in breast cancer.
Wahal SP; Goel MM; Mehrotra R
J Cancer Res Ther; 2015; 11(4):798-804. PubMed ID: 26881521
[TBL] [Abstract][Full Text] [Related]
4. The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value.
Bolenz C; Auer M; Ströbel P; Heinzelbecker J; Schubert C; Trojan L
Urol Oncol; 2013 Nov; 31(8):1606-14. PubMed ID: 22503575
[TBL] [Abstract][Full Text] [Related]
5. Comparison of lymphangiogenesis, lymphatic invasion, and axillary lymph node metastasis in breast carcinoma.
Guleria P; Srinivas V; Basannar D; Dutta V
Indian J Pathol Microbiol; 2018; 61(2):176-180. PubMed ID: 29676352
[TBL] [Abstract][Full Text] [Related]
6. Lack of lymphangiogenesis during breast carcinogenesis.
Vleugel MM; Bos R; van der Groep P; Greijer AE; Shvarts A; Stel HV; van der Wall E; van Diest PJ
J Clin Pathol; 2004 Jul; 57(7):746-51. PubMed ID: 15220369
[TBL] [Abstract][Full Text] [Related]
7. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.
Rabban JT; Chen YY
Hum Pathol; 2008 Feb; 39(2):175-83. PubMed ID: 18206495
[TBL] [Abstract][Full Text] [Related]
8. Relationship between high density of peritumoral lymphatic vessels and biological behavior of cervical cancer.
En-Lin S; Wei-Wei Y; Xiao-Liang X; Juan X
Int J Gynecol Cancer; 2012 Oct; 22(8):1435-41. PubMed ID: 22968518
[TBL] [Abstract][Full Text] [Related]
9. Can lymphatic vascular density be used in determining metastatic spreading potential of tumor in invasive ductal carcinomas?
Kandemir NO; Barut F; Bektas S; Ozdamar SO
Pathol Oncol Res; 2012 Apr; 18(2):253-62. PubMed ID: 21785902
[TBL] [Abstract][Full Text] [Related]
10. Absence of lymphangiogenesis in ductal breast cancer at the primary tumor site.
van der Schaft DW; Pauwels P; Hulsmans S; Zimmermann M; van de Poll-Franse LV; Griffioen AW
Cancer Lett; 2007 Aug; 254(1):128-36. PubMed ID: 17442484
[TBL] [Abstract][Full Text] [Related]
11. Podoplanin as Key Player of Tumor Progression and Lymph Vessel Proliferation in Ovarian Cancer.
Cobec IM; Sas I; Pirtea L; Cimpean AM; Moatar AE; Ceaușu RA; Raica M
Anticancer Res; 2016 Oct; 36(10):5265-5272. PubMed ID: 27798887
[TBL] [Abstract][Full Text] [Related]
12. Lymphangiogenesis assessed using three methods is related to tumour grade, breast cancer subtype and expression of basal marker.
Niemiec J; Adamczyk A; Ambicka A; Mucha-Małecka A; Wysocki W; Mituś J; Ryś J
Pol J Pathol; 2012 Nov; 63(3):165-71. PubMed ID: 23161232
[TBL] [Abstract][Full Text] [Related]
13. Podoplanin expression in cancer-associated fibroblasts correlates with VEGF-C expression in cancer cells of invasive ductal breast carcinoma.
Pula B; Wojnar A; Witkiewicz W; Dziegiel P; Podhorska-Okolow M
Neoplasma; 2013; 60(5):516-24. PubMed ID: 23790170
[TBL] [Abstract][Full Text] [Related]
14. Significance of pathological evaluation for lymphatic vessel invasion in invasive breast cancer.
Ito M; Moriya T; Ishida T; Usami S; Kasajima A; Sasano H; Ohuchi N
Breast Cancer; 2007; 14(4):381-7. PubMed ID: 17986803
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral but not peritumoral lymphatic vessel density measured by D2-40 expression predicts poor outcome in gastric cancer--ROC curve analysis to find cut-off point.
Donizy P; Rudno-Rudzinska J; Halon A; Dziegala M; Kabarowski J; Frejlich E; Dziegiel P; Kielan W; Matkowski R
Anticancer Res; 2014 Jun; 34(6):3113-8. PubMed ID: 24922680
[TBL] [Abstract][Full Text] [Related]
16. Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression.
Sotiropoulou N; Bravou V; Kounelis S; Damaskou V; Papaspirou E; Papadaki H
Pathology; 2010 Dec; 42(7):629-36. PubMed ID: 21080871
[TBL] [Abstract][Full Text] [Related]
17. Regional difference in intratumoral lymphangiogenesis of oral squamous cell carcinomas evaluated by immunohistochemistry using D2-40 and podoplanin antibody: an analysis in comparison with angiogenesis.
Ohno F; Nakanishi H; Abe A; Seki Y; Kinoshita A; Hasegawa Y; Tatematsu M; Kurita K
J Oral Pathol Med; 2007 May; 36(5):281-9. PubMed ID: 17448138
[TBL] [Abstract][Full Text] [Related]
18. Lymphatic vessel density is not associated with lymph node metastasis in non-small cell lung carcinoma.
Faoro L; Hutto JY; Salgia R; El-Zayaty SA; Ferguson MK; Cheney RT; Reid ME; Armato SG; Krausz T; Husain AN
Arch Pathol Lab Med; 2008 Dec; 132(12):1882-8. PubMed ID: 19061284
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated lymphangiogenesis in the development of conjunctival squamous cell carcinoma.
Heindl LM; Hofmann-Rummelt C; Adler W; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2010 Apr; 117(4):649-58. PubMed ID: 20346821
[TBL] [Abstract][Full Text] [Related]
20. Lymphangiogenesis and expression of specific molecules as lymphatic endothelial cell markers.
Kato S; Shimoda H; Ji RC; Miura M
Anat Sci Int; 2006 Jun; 81(2):71-83. PubMed ID: 16800291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
